CCL18 Production in Neutrophils of Rheumatoid Arthritis Patients
Author Information
Author(s): Judith Auer, Markus Bläss, Hendrik Schulze-Koops, Stefan Russwurm, Thomas Nagel, Joachim R. Kalden, Martin Röllinghoff, Horst Ulrich Beuscher
Primary Institution: University of Erlangen-Nuremberg
Hypothesis
Can polymorphonuclear neutrophils (PMN) in synovial fluid produce CCL18 in rheumatoid arthritis?
Conclusion
The study found that synovial fluid PMN from rheumatoid arthritis patients are a significant source of CCL18, which is tightly regulated at the levels of mRNA expression and protein synthesis.
Supporting Evidence
- CCL18 mRNA was highly expressed in synovial fluid PMN from RA patients compared to blood PMN from healthy donors.
- IL-10 was sufficient to induce CCL18 release from SF PMN.
- TNF-α induced CCL18 mRNA expression but not protein synthesis in blood PMN.
Takeaway
Doctors found that certain immune cells in the joints of arthritis patients can make a special protein called CCL18, which helps attract other immune cells to the area.
Methodology
The study used microarray analysis, semiquantitative and quantitative RT-PCR to analyze CCL18 production in PMN from synovial fluid and blood.
Potential Biases
Potential bias due to the small number of patients and the specific selection criteria for RA patients.
Limitations
The study was limited to a small sample size of patients and did not explore the long-term effects of CCL18 production.
Participant Demographics
Nine patients with active rheumatoid arthritis, including both males and females aged 35 to 80.
Statistical Information
P-Value
0.2612
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website